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ABSTRACT

Microarray technology is a useful tool for studying the expression levels of
thousands of genes or exons within a single experiment. Data from microarray
experiments present many challenges for researchers since costly resources often limit
the experimenter to small sample sizes and large amounts of data are generated. The
researcher must carefully consider the appropriate statistical analysis to use that aligns
with the experimental design employed. In this work, statistical issues are investigated
and addressed for a microarray experiment that examines how expression levels change
over time as individuals are sleep deprived. Over the course of 48 hours of sleep
deprivation, RNA is collected from saliva samples of two study participants. These
samples were hybridized to exon microarrays to measure gene and exon expression at
three different time points. Five different statistical analyses are conducted to test for
expression differences over time. These analyses are carefully scrutinized and a thorough
investigation is conducted on the microarray data. The different analyses elicited
different findings. Several genes and exons are identified as differentially regulated over
time and should be examined closer with regard to their relationship to sleep deprivation.
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1. INTRODUCTION

1.1 GENERAL OVERVIEW

There are many different reasons why scientists study the human genome. The
study of gene expression has commonly focused on detecting significant differences in
the expression patterns of genes [1]. These differences are then explored further and
studied in conjunction with diseases or inherited traits. Through the use of gene
expression studies specific genes have been linked to certain diseases. Also these patterns
have greatly aided in predicting the outcomes for these epidemics as well as determining
treatments and courses of action. Just as there are many different reasons one might want
to study gene expression patterns, there are different tools used to obtain information
about the genes. Figure 1.1 shows the different components of a gene.

Figure 1.1 Exons Contained Within a Gene

A gene is a section of DNA located on a part of a chromosome containing
chemical information necessary to specify certain proteins from RNA [2]. Genes contain
relevant information that make each organism's cells and help to pass genetic information
and traits to their offspring. Every living being has many different genes, each linked to
various biological traits. There are approximately 20,000 genes in the human genome that
are responsible for encoding proteins and RNA chains. In the genes of certain organisms
that have a membrane bound nucleus, protein sequences are interrupted by stretches of
DNA called introns. The introns are taken from the primary transcript during the
formation of mRNA and the coding sequence that is left between the introns is called an
exon. An exon is a sequence encoded by a gene that remains present within the final
mature RNA product of that gene after introns have been removed via RNA splicing. The
term exon refers to both the DNA sequence within a gene and to the corresponding
sequence in RNA transcripts. Each gene contains many, different numbers of exons,
hence there are more exons than there are genes as shown in Figure 1. 1.
Just as there are many different reasons to study gene expression, there are also
different methods that can be used to measure gene expression. Microarray analysis is a
very popular method in which genes are studied. In a microarray analysis, mRNA is
isolated from a tissue sample such as a saliva or blood sample; it is then copied several
times through a process called PCR, or polymerase chain reaction [3]. Once a large
quantity of mRNA has been made, it is chopped up into millions of short pieces. The
short mRNA pieces are then labeled and loaded into a microarray for gene expression
quantification as shown in Figure 1.2.
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Figure 1.2 Microarray Technologies

After the microarray data are collected, they are generally stored in .CEL files. A
statistical software package R Bioconductor [4], more specifically the “Biobase” and
“Oligo” libraries can be used to read the gene expression data. The RMA (Robust
Multichip Average) method is used to preprocess the data into a usable format. The RMA
process consists of three steps; background correction, quantile normalization and lastly
summarization [5]. A background correction method adjusts the data for noise and cross
hybridization. This step also scales the data appropriately for the analysis. Quantile
normalization is the process of reducing unnecessary variation among the biological
information. The arrayed data is scaled so that the quantiles of each probeset are equal
and have the same distribution across all arrays within a treatment group. Lastly, the data
is summarized as a gene expression measure and is sent to the output file i.e. multiple
probes from the same gene are summarized so that we have one expression measurement
per gene or exon.
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1.2 MICROARRAY DATA
Since gene expression measures help to study several biological variants in the
human genome, it makes sense to think that a person’s sleeping pattern might affect the
overall gene expression as well. The goals of the following analyses are to determine if
any genes or exons are significantly expressed differently after sleep deprivation and
identify the pattern, if any they follow over time. For the analysis, RNA from two human
subjects was collected at three times: baseline prior to any sleep deprivation, after 24
hours without sleep and finally after 48 hours of being sleep deprived. RNA was
extracted from a saliva sample from each subject and hybridized to an Affymetrix Human
Exon 1.0 ST microarray [6], resulting in expression data from six different microarrays.
Table 1.1 shows the experimental set up where yij equals the expression level of subject j
at time i for a particular gene or exon.

Table 1.1 Experimental Observations
Microarray Data
Baseline

24 Hours

48 Hours

Subject 1

Y11

Y21

Y31

Subject 2

Y12

Y22

Y32

The objective is to detect genes/exons that are differentially expressed between
the different times, giving a measure of which genes/exons may be associated with sleep
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deprivation. The initial experiment examined 22,011 genes and 1,411,399 exons,
however some of the biological units did not have reliable evidence supporting the
transcription or mapping of the genomic sequence. Possible evidence levels included for
the probe sets are core, extended and full. The most reliable evidence level obtained is
classified as “core”. This classification refers to probe sets fully supported by RefSeq [7]
and mRNA GenBank [8] or can be assigned reliably to a particular transcript cluster.
Core was the only evidence level classification that was used for our analysis. After
discarding the genes and exons whose evidence level was identified as extended or full
we were left with 17,874 genes and 284,805 exons. A common theme throughout this
study is testing the difference between the three time points, baseline, 24 and 48 hours.
Several different tests were conducted to measure the difference between the three
comparisons. This study deals with a few statistical issues as well. First of all there is a
small sample size, and a lot of data being tested. Also there is a question of dependency
in the biological units being compared. After both of these issues are combined into
analyzing one set of data, tradeoffs are made in each test that is conducted. If one
assumes that the data are dependent over time, fewer degrees of freedom are available
with an already small sample. On the other hand, if the data is assumed to be independent
over time, the variance will likely be inflated. Both of these options result in lowering the
power of the tests conducted, so choosing an appropriate analysis is important. The study
below analyzes the biological data at both the gene and exon level. As mentioned
previously, there can be many exons per gene, so the exon level analysis is considerably
lengthier. However the exon level data is specifically of interest because it is possible that
in the saliva samples we may see cases where exons within the same gene show different
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expression patterns. Also saliva degrades RNA, so specific exons may contain the most
information. It is important to test at the exon level since the gene level analysis results
may miss important differences, for example in a single exon when the probes are
summarized across the whole gene.
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2. STATISTICAL ANALYSIS - DEFINITIONS

2.1 T-TEST
The t-test is a statistical test that evaluates whether or not a population mean is
equal to some value [9]. A t-test can be performed for one sample, two samples, and
paired observations. In all three of these various t-tests, the true population mean and
standard deviation are unknown. This is why a statistical test is conducted to test whether
the true population mean is equal to some value. A one-sample t-test will test whether the
population from which a sample was drawn has a mean value equal to a specific number
thought to be the true mean. An independent two-sample t -test compares the means of
two normally distributed populations. The two random samples taken from populations
are assumed to be independent, meaning the first sample should not influence the second.
Generally the test being conducted for an independent t-test is whether there is a
difference between the two population means. The paired t-test on the other hand looks at
the mean of the differences of two matched pairs or samples. In the paired t-test the
population mean that is being tested is the mean difference or the average difference
between the two sets of observations. Generally the hypothesis being tested for the paired
t-test is that the mean difference is equal to zero. It is logical to assume that due to
sampling error the sample mean will not be exactly equal to some theoretical value or the
difference between two sample means will not be exactly zero even if this is true in the
population. This is often due to random sampling error. The t-test tells us whether or not
the true population mean differs from the value in question due to random sampling error
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or due to true population differences. The main difference between the independent t-test
and the paired t-test is that the paired test deals with how the data are collected on the
statistical units in question. If the data measurements are taken on the same statistical
units or we expect the data to have some correlation, a paired t-test is appropriate. If the
difference being measured between the observations should not have any correlation or
dependencies an independent t-test is the better analysis.
2.1.1. Independent Two Sample T-Test: General Definition. An independent
two sample t-test is a statistical test that measures the population mean difference
between two independent populations [9]. In laymen’s terminology, this means that two
different populations are being observed or analyzed, and the measured response in one
group should not influence the response in the other group in any way.
2.1.1.1 Assumptions. When performing an independent t-test, certain criteria
should be met. The measured observations for each group should follow a normal
distribution. This can be tested by looking at a normal probability plot and/or plotting a
frequency histogram for the response variables. The normal probability plot that is
observed should resemble an approximately straight line and the frequency histogram
should be unimodal and fairly symmetric. Next, the measured observations must be
obtained from different/unrelated statistical units. This should be the case for both the
statistical units that are being compared to one another in different groups as well as the
units in the same population group. Lastly, the variances for the two groups are assumed
to be equal to one another.
2.1.1.2 Hypothesis tests. The hypotheses being tested for the independent t-test
are given below.
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Null Hypothesis: The population means from the two unrelated groups are equal:
Ho: µi - µi’ = 0.
Alternative Hypothesis: The population means from the two groups are not equal:
Ha: µi - µi’ ≠ 0.
Here we define yij to be the response value for the jth individual (j=1,…,n) under
treatment i (i=1,2).
2.1.1.3 Test statistic. The t-statistic for the independent t-test is computed by:
T

y1  y2
. Where we assume an equal sample size for the respective groups equal to
1 1
sp

n n

n and y1 and y2 are the sample means for the two independent groups respectively. sp is
the pooled sample standard deviation for the data and s2p is the pooled sample variance

(n  1) s12  (n  1) s22
for all of the data calculated by s 
. The pooled standard deviation
nn2
2
p

is simply the square root of the pooled variance. The significant level of a hypothesis test
represents the probability of committing a Type I error or a false positive result.
Commonly, studies set the significance level alpha (α) to be 0.05 or 0.1 and obtain the t
critical value by t,2( n 1) . We compare the t-statistic to the t-critical value and reject the

null hypothesis if |T| > t(α/2,2(n-1)). A p value is obtained after calculating the t-statistic. The
p value represents the probability of obtaining a test statistic at least as extreme as what
we did, if the null hypothesis is really true. We can think of the p value as the probability
that the difference between the two sample means happened due to pure chance and not
because there is a true difference. For example, a p-value of .05 suggests that there is a
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5% probability that the difference between the means obtained from the sample was
indeed random or by occurred chance. In other words, assuming that in the true
population there was no difference in the means whatsoever, and this experiment was
repeated one time after another, approximately one in every 20 replications might elicit a
false positive claim that there is sample evidence to suggest a difference between
population means. The smaller the p value the less likely we are to commit a Type I error.
This is why we report p values rather than solely rejection conclusions.
2.1.2. Independent Two Sample T-Test: Microarray Data. For this analysis,
gene expression differences are examined between three time intervals. The expression
measures are taken from the beginning of the trial (baseline), after 24 hours of sleep
deprivation, and finally after each subject had gone 48 hours without sleep. An
independent t-test is performed for each gene/exon three times. The first test compared
the mean expression of the two subjects at baseline to that at 24 hours, the second test at
baseline and 48 hours and the last at 24 and 48 hours. Although there is reason to believe
the two samples are not independent since the data were collected on the same person,
first an independent sample t-test is conducted to examine whether or not the genes and
exons are correlated over time. It is logical to assume that some of the genes will be
correlated while others may not. These results are compared to those of a paired t-test to
examine this correlation.
2.1.2.1 Assumptions. For our microarray data, we assume that the biological
expressions of the two populations follow a normal distribution. Since the sample size is
only two, we are not able to draw conclusions based on the appropriate tests for
normality. We would always be able to draw a straight line between only two different
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observations. However previous studies with larger sample sizes report that the gene
expressions follow the normal distribution [10]. Furthermore, the t-test is robust against
departures from normality. Our study examines expression measures for two individuals
over a 48 hour time period of sleep deprivation. The data was analyzed looking at
differences from the same individual amongst the times measured; however it is not
unreasonable to assume that some genes and exons wouldn’t be related over time. Also
one subject’s expression measure should not influence the others, thus the subjects are
independent of one another. Finally, we assume that the variance is similar at the three
different time points.
2.1.2.2 Hypothesis tests. The specific hypotheses being tested for each gene or
exon are given below. The expression measure is represented by yij for the jth subject
(j=1, 2) at time i (i=1, 2, 3) for an individual gene or exon. The mean for each treatment
time is calculated and compared to one another.
Null Hypothesis:
1.) There is no difference in mean expression measure between the baseline and 24 hours
of sleep deprivation: µ1 - µ2 = 0
2.) There is no difference in mean expression measure between the baseline and 48 hours
of sleep deprivation: µ1 - µ3 = 0
3.) There is no difference in mean expression measure between 24 and 48 hours of sleep
deprivation: µ2 - µ3 = 0
Alternative Hypothesis:
1.) There is a difference between the two means at baseline and 24 hours: µ1 - µ2 ≠ 0
2.) There is a difference between the two means at baseline and 48 hours: µ1 - µ3 ≠ 0
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3.) There is a difference between the two means at 24 and 48 hours: µ2 - µ3 ≠ 0
2.1.2.3 Test statistic. A t-statistic is calculated multiple (17,874 times for the
gene level analysis and 284,805 times for the exon level analysis) times. The two sample
treatment means are subtracted from one another and compared to the pooled standard

s12  s22
sp 
2 . In our study the sample size is two for all three treatments.
deviation or
This gives us two degrees of freedom. After the t-statistics are all computed, they are
compared to the t-critical value T~t(α/2,2), or |T| > 4.303 for an alpha equal to 0.05.
2.1.3. Paired T-Test: General Definition. A paired t-test is a statistical test that
measures the population mean difference between two dependent populations [9]. In
laymen’s terminology, this means that population difference that is observed or analyzed
should be taken from related or similar statistical units.
2.1.3.1 Assumptions. When performing a paired t-test, certain criteria should be
met. First, one needs to assume that the paired differences follow a normal distribution.
This can be tested by looking at a normal probability plot, and/or plotting a frequency
histogram of the paired differences. Next, the matched differences must be obtained from
the same statistical unit or a matched pair. This might mean looking at differences from
the same person, plot of land, piece of machinery, etc. The key is that the two
measurements should be related in some way or another. Finally, all of the paired
differences should be independent of one another, meaning the difference of one
statistical unit should not influence another.
2.1.3.2 Hypothesis tests. The hypotheses being tested in the paired t-test are
given below.
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Null Hypothesis: The population mean difference is zero or Ho: µd = 0.
Alternative Hypothesis: The population mean difference is not zero or Ha: µd ≠ 0.
Here we define yij to be the response value for the jth individual (j=1,…,n) under
treatment i (i=1,2). These can be used to calculate paired differences dj = y1j – y2j which
represent the difference in response of the jth individual between treatments 1 and 2. In
the hypothesis, µd represents the population mean of the differences. The paired t-test is
actually a one-sample t-test on the paired differences.
T

2.1.3.3 Test statistic. The t-statistic is computed by:

d
sd / n . Where d is the

n

d
j 1

sample mean of the paired differences, computed by d =

n

j

, s2d is the sample

variance of the paired difference, sd the sample standard deviation of the paired
n

sd 
differences, calculated by

 (d
j 1

j

 d )2

n 1

and n is the sample size.

2.1.4. Paired T-Test: Microarray Data. For this analysis, differences in gene or
exon expression were examined between three time intervals. Expression measures were
obtained from the beginning of the trial (baseline), after 24 hours of sleep deprivation,
and finally after each subject had gone 48 hours without sleep. A paired t-test is
performed for each gene/exon three times. The first test compared the mean expression of
the two subjects at baseline to that at 24 hours, the second test at baseline and 48 hours
and the last at 24 and 48 hours. Since this part of the analysis looks to examine any
differences between time points of the same subjects, a paired t-test was selected over an
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independent, two-sample t-test. A degree of freedom is lost in performing this type of
analysis, however if there is a positive correlation between the data collected on the same
individual, there should also be less variance at the different time points. Because of the
reduction in variance, the paired t-test can be more powerful than the independent t-test,
especially in larger sample sizes when the correlation is moderately high. It is unclear
from the data whether there will be such an improvement in variance reduction or not.
The paired t-test will be compared to the independent t-test to examine this.
2.1.4.1 Assumptions. For the microarray data, it is assumed that the paired
differences follow a normal distribution. Since the sample size is only two, a test for
normality cannot be conducted. However previous studies with larger sample sizes report
that the paired differences follow this normal distribution [10]. This study examines
expression measures for two individuals over a 48 hour time period of sleep deprivation.
The data was analyzed looking at differences from the same individual amongst the times
measured. The time points baseline, 24 and 48 hours should have some correlation in
expression measure for the same individual. Lastly, one of the individual’s expression
measures should not influence the other over the different times.
2.1.4.2 Hypothesis test. The specific hypotheses being tested for each gene or
exon are given below. The expression measure is represented by yij for the jth subject
(j=1, 2) at time i (i=1, 2, 3) for an individual gene or exon. The paired differences are
calculated by dij = yij – yi’j, which is the expression difference for the jth subject at time
i and i’ (where i ≠ i’). In the hypotheses below, µdii’ represents the population mean of
the differences at times i and i’.
Null Hypothesis:
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1.) There is no difference in mean expression measure between the baseline and 24 hours
of sleep deprivation: µd12 = 0.
2.) There is no difference in mean expression measure between the baseline and 48 hours
of sleep deprivation: µd13 = 0.
3.) There is no difference in mean expression measure between 24 and 48 hours of sleep
deprivation: µd23 = 0.
Alternative Hypothesis:
1.) There is a difference between the two means at baseline and 24 hours: µd12 ≠ 0.
2.) There is a difference between the two means at baseline and 48 hours: µd13 ≠ 0.
3.) There is a difference between the two means at 24 and 48 hours: µd23 ≠ 0.
2.1.4.3 Test statistic. A t-statistic is calculated multiple (17,874 times for the
gene level analysis and 284,805 times for the exon level analysis). The sample mean
difference is calculated by summing the differences across time points from the
individuals and dividing by the sample size. In our study the sample size is two, or n = 2.
This leaves us with only one degree of freedom. A t-distribution with only one degree of
freedom is also known as a Cauchy distribution. A comparison of the Cauchy distribution
to a normal distribution is shown in Figure 2.1. Notice how the bell curve captures more
observations around the mean while the Cauchy distribution has many observations
falling under the thick right and left tails. After the t-statistics are all computed, they are
compared to the t-critical value T~t(α/2,1), or |t| > 12.706 for an alpha equal to 0.05.
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Figure 2.1 Normal vs. Cauchy Distribution

2.2 ANALYSIS OF VARIANCE
2.2.1. General Definition. A one-way analysis of variance (ANOVA) is similar to an
independent two-sample t-test in that the test compares the population means for different
treatment groups. A key difference between the two is that a one-way ANOVA allows for
testing differences in population means when there are more than two treatment groups,
and they are compared all at once. In general, ANOVA can test both main effects as well
as interaction effects between the experimental variables [9]. The interaction effects looks
at and tests a combination of variables, this is a multiplicative effect. In general, ANOVA
allows for multiple main effects. These effects are additive. However for a one-way
ANOVA, only one main effect is considered. A main effect measures the effect of one
treatment variable against the response variable. It is different from the t-test because
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here we can compare more than two means at one time. Also, the error degrees of
freedom will increase and allows a better estimate of the error variance. Two different
one-way ANOVA models can be considered:
Factor Effects Model:
Yij = µ + τi + εij
Yij = Response for ith treatment, jth replicate i = 1, 2, …, a and j = 1, 2, …, n
µ = Overall mean
τi = Treatment effect for i = 1, 2, …, a
iid

εij = Error for ith treatment, jth replicate  ij ~ N (0,  2 )
a

and



i

 0 since the model is over parameterized.

i1

Cell Means Model:
Yij = µi + εij
Yij = Response for ith treatment, jth replicate i = 1, 2, …, a and j = 1, 2, …, n
µi = Overall mean of treatment i, i =1, 2, …, a
iid

εij = Error for ith treatment, jth replicate  ij ~ N (0,  2 )

Table 2.1 ANOVA Table
Anova
Source

Degrees of Freedom

Sums of Squares

Mean Squared

a

Y2 Y2
  i   
N
i1 n

SSTreatment
Treatment

(a-1)

a

n

SSError   Yij  Yi 
Error
Total

(N-a)
(N-1)

2

i 1 j1

SSTotal  SSTreatment  SSError

F Statistic

Critical F Value

MSTreatment  SSTreatment /  a  1 F  MSTreatment / MS Error Fa 1, N  a
MS Error  SS Error /  N  a 
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Table 2.1 is summarized below:
N is equal to a  n or the total number of observations. The total sum of squares can also
a

be computed by: SSTotal =

n

 (Y
i 1 j 1

ij

 Y  )2 and can be thought of as the sums of squares

composed of both error and the treatment. It is used to measure the overall variability of
the data. Dividing the SS Total by the total degrees of freedom, you obtain the sample
variance of the yij’s. The total sum of squares can be thought of as being partitioned
between a sum of squares differences between the treatment averages and grand mean
(Sum of Squares Treatment) plus the sum of squares of the differences of observations
within the treatments from the treatment average (Sum of Squares Error). In the SS Error
n

term, if we divide  ( yij  y i )2 by (n – 1), this is the sample variance for the ith
i 1

treatment. If we look at a (treatment levels) sample variances and combine them all
together we obtain a single estimate of the population variance. This is equal to
a

n

 (Y
i 1 j 1

ij

 Y i )2

or

N a

, the Mean Squared Error, a pooled estimate of the variance

across all of the treatments. If there aren’t differences between the treatment means, use
the variation of the treatment averages subtracted from the grand mean to estimate the
a

n (Yi  Y  ) 2
variance

i 1

a 1

or

, the Mean Squared Treatment. This is a valid

estimate for the variance when the treatment means are equal. There are now two
different ways to estimate the variance. One is based on variation within the treatments
(MSE), the other looks at variability between the treatments (MSTreatments). When there is
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no difference between the treatment means (the null hypothesis is true), the two mean
squares should be very similar. If that is the case, the ratio between the two will elicit an
F value near 1. Only if the F statistic is large enough relative to noise and signal in the
data will we reject the null hypothesis in favor of the alternative.
2.2.1.1 Assumptions. Some assumptions need to be met for the ANOVA model
to be valid, mainly concerning the residuals of the error term, εij. These residuals are
assumed to be normally, randomly distributed with a mean of zero and a common
variance  . The residuals should be independent of one another, meaning the error from
2

one observation should not influence another. Common types of residual plots are shown
in Figure 2.2 The common variance assumption means that the residuals for the error
term should be equal among all treatment groups, or the residuals are homogeneous.

Figure 2.2 Diagnostic Plots for Residuals

20

Diagnostic tests are employed to evaluate these assumptions. One diagnostic test
is a plot of the residuals versus the predicted values. Also the residuals can be plotted
against the different treatment levels. The residual plots should look random and equally
varied. If there is a clear trend in the plot of the residuals the model may need to be reevaluated. Another item to observe is the normal probability plot. This will test to see if
the data is normally distributed.
2.2.1.2 Overall f-test for equality of treatment means. The hypothesis being
tested for the overall ANOVA is as follows (for the Factor Effects Model):
Null Hypothesis: There is no difference between any of the population means for the
treatment effects, or τ1 = τ 2 = … τ a = 0 (where a = number of treatment effects).
Alternative Hypothesis: At least one of the population means for the treatment effects
differs from one of the others, or τi ≠ 0 for at least one i.
2.2.1.3 F-statistic. The F-Statistic is computed by:
SSTreatment
MSTreatments
(a  1)
F0 =
or
where a = the number of treatment groups and N =
SS Error
MS Error
( N  a)

the total number of observations, or yij.. Commonly, studies chose alpha to be 0.05 or 0.1
and obtain an F critical value by Fα, a-1, N-a as shown in Figure 2.3. This F critical value is
compared to F0 and we reject the null hypothesis when F0 > Fα, a-1, N-a. After F0 is
compared to the F critical value, if one decides to reject the null hypothesis that one of
the treatment means is indeed different than the others, there are a few other tests that can
be conducted to make statistical inferences regarding the differences in treatment means.
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Figure 2.3 F Distribution with 2 Numerator and 3 Denominator Degrees of Freedom

2.2.1.4 Contrasts for the ANOVA model. A contrast is a linear combination of
a

the factor level population means defined as
a

c
i 1

i

L  c11  ...  ca a

or

c 
i 1

i

i

where

0

. An orthogonal contrast is a contrast whose sum of the coefficients sum to zero

[9]. Also the cross product of the coefficients should equal zero as well. The numbers of
different orthogonal contrasts that can be observed are equal to the degrees of freedom
for the treatment group, or the numerator degrees of freedom from the overall F test.
Contrasts are generally useful in analyzing pre-planned comparisons for the data, or
comparing treatment groups that the experimenters might already suspect to have
differences before analyzing data.
There are many different hypotheses to test when examining contrasts. Generally,
assume that the coefficients, ci sum to zero, a general way to write the hypothesis tests
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are as follows:
a

H0: L =  ci i  0
i 1

a

Ha:

c 
i 1

i

i

0

The test statistic for the different contrasts of a one-way ANOVA model each
follows a t-distribution. The contrast is written in terms of the sample treatment averages,
a

c y
i 1

i

i

and is compared to the mean square error. The test statistic is as follows:
a

t0 

c y
i 1

MS E
n

i

i

. This test uses the same degrees of freedom as the denominator

a

c
i 1

2

i

degrees of freedom (i.e. the error degrees of freedom) as the overall F test and the null
hypothesis is rejected if |t0| > tα/2,N-a.
2.2.1.5 Pairwise comparisons for the ANOVA model. In some cases,
researchers might be interested in only comparing two treatments, or pairs of means to
one another. These are called pairwise comparisons and can be essentially thought of as a
special type of contrast where only two of the treatment means have coefficients that are
not equal to zero. One of the ci’s of interest will be equal to one and the other negative
one. These pairwise comparisons are orthogonal because the coefficients sum to zero.
The pairwise comparisons are similar to an independent t-test in that we are comparing
two of the treatment means at one time, however the variance is computed differently and
degrees of freedom are gained. If the variance estimate is decreased then this test should
detect more differences than what would be found in a two-sample independent t-test.
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The hypothesis test for the pairwise comparisons are similar again to the
hypothesis for the contrasts only more specific because it only tests the difference of two
population means. The null and alternative hypothesis tests are as follows:
Ho: µi - µi’ = 0 or the two population treatment means are equal to one another.
Ha: µi - µi’ ≠ 0 or the two population treatment means are not equal to one another.
Again, the test statistic for the pairwise comparisons is similar to that of the contrasts. It
also follows a t-distribution and is written in terms of the treatment averages. However
since it is only testing the difference between two means, the general form is t0 =
yi  yi'
2
n

MS E

Again this test statistic is compared to a critical t-value that is equal to tα/2,N-a

and we reject the null hypothesis when |t0| > tα/2,N-a.
2.2.2. Microarray Data. The microarray data in this experiment was gathered at
several different time points, so it makes sense to test differences between the means of
the different times. Again, this is different from the independent t-test because multiple
means at one time as opposed to two. Table 2.2 gives a general overview of the
expression measures for each gene/exon.
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Table 2.2 Observations and Means for Microarray Data
Microarray Data
Subject
Means

Baseline

24 Hours

48 Hours

Subject 1

Y11

Y21

Y31

Y1

Subject 2

Y12

Y22

Y32

Y2

Treatment
Means

Y1

Y2

Y3

Y

Each subject has expression measures collected over the different time points, Yij ,

Y i is the treatment mean for the ith time point, Y  j is the mean for the jth subject and Y
is the overall mean across all subjects and time points. These treatment means are
compared to one another and tested to see if there are any statistically significant
differences at the population level. The two alternate formulations of the one-way
ANOVA here are:
Factor Effects Model:
Yij = µ + τi + εij
Yij = Expression for ith treatment, jth replicate i = 1, 2, 3; j = 1, 2
µ = Overall mean
τi = Treatment effect, i = 1, 2, 3
iid

εij = Error for ith treatment, jth replicate i = 1, 2, 3; j = 1, 2 εij ~ N(0,σ2)
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3

and



i

 0 since the model is over parameterized.

i1

Means Model:
Yij = µi + εij
Yij = Expression for ith treatment, jth replicate i = 1, 2, 3 j = 1, 2
µi = Overall mean of treatment i, i = 1, 2, 3
iid

εij = Error for ith treatment, jth replicate i = 1, 2, 3 j = 1, 2 εij ~ N(0,σ2)
Table 2.1 shows the general ANOVA table, but the degrees of freedom can be
specifically updated given the number of different treatments and replicates in the study.
The treatment degrees of freedom are generally computed as (a-1). For the microarray
data this is equal to two. The error degrees of freedom are calculated as (N-a) where N is
the total number of observed expressions. For this data set, N = 6 so the error degrees of
freedom is 3. The total degrees of freedom can be figured by (N-1) or (a-1) + (N-a),
which is equal to 5 total degrees of freedom.
2.2.2.1 Assumptions. While certain assumptions should be met for the ANOVA
model to be valid, just like in the independent t-test we assume that these assumptions
hold true. It is difficult to test the residuals of the error term simply because we have a
small sample size. We assume that the error terms are normally, randomly distributed
around zero and that they are independent of one another. We will account for the
potential dependence between observations on the same subject in a repeated measures
model. The results of these two models will be compared to examine the potential
correlation in the data.
2.2.2.2 Overall f-test for equality of treatment means. The specific hypotheses
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being tested for each gene or exon are given below. The treatment effect mean is
represented by τi at time i (i=1, 2, 3) for an individual gene or exon when using the factor
effects model. Alternatively, if the cell means model is employed, the treatment mean is
represented by µi at time i (i=1, 2, 3). The null and alternative hypothesis are listed
below:
Null Hypothesis: τ1 = τ2 = τ3 = 0 or all of the treatment effects are equal to zero or
µ1 = µ2 = µ3 the treatment means are all equal.
Alternative Hypothesis: At least one of the τi’s is not equal to zero or not all µi’s
are equal.
2.2.2.3 F-statistic. The F-statistic is computed for each gene or exon after the
ANOVA table from Table 2.1 is calculated for each individual biological unit. It is
figured by F0 =

SSTreatment 2
and is then compared to the critical f-value or F0.05, 2, 3, which
SS Error 3

is 9.55. When F0 is greater than 9.55 the null hypothesis is rejected because there is
sufficient evidence to suggest that the population treatment means/effects are not all
equal to one another.
2.2.2.4 Contrasts and pairwise comparisons. For the microarray data all of the
orthogonal contrasts were tested. Since there are three different treatment groups there
are two degrees of freedom associated with the treatment effect. Therefore there are two
different orthogonal contrasts to test. The first contrast compares the mean of one
treatment group to that of the other two or C1  1  12 (2  3 ) and this is done three
times so that each mean is compared to the other two. The other orthogonal contrast
compares only two of the means to each other. Again, this contrast can be thought of as a

27

pairwise comparison because it is comparing a set of paired data. C2  1  2 is tested
so that the each treatment mean is compared to the other.
The hypothesis test for the first contrast, C1 for the microarray data is as follows:
Ho1: 2µ1 - µ2 - µ3 = 0 Ha1: 2µ1 - µ2 - µ3 ≠ 0
Ho2: 2µ2 - µ1 - µ3 = 0 Ha2: 2µ2 - µ1 - µ3 ≠ 0
Ho3: 2µ3 - µ1 - µ2 = 0 Ha3: 2µ3 - µ1 - µ2 ≠ 0
The hypothesis that is being tested for C1 is whether the treatment means of group i is
different than the average of the other two treatment means. Each null hypothesis posits
that there is no difference between the population treatment means while the alternative
states that there is difference. The hypothesis test for C2 or the pairwise comparisons are
as follows:
Ho1: µ1 - µ2 = 0

Ha1: µ1 - µ2 ≠ 0

Ho2: µ1 - µ3 = 0

Ha2: µ1 - µ3 ≠ 0

Ho3: µ2 - µ3 = 0

Ha3: µ2 - µ3 ≠ 0

These hypotheses are testing to see if there is a difference between two of the treatments.
Again, each null hypothesis states that there is no difference between the two population
treatment means, the alternative stating that there is a difference in the means. For the
contrast C1 a t-statistic is calculated for each gene and exon. For the pairwise
comparisons, each gene and exon has a test statistic. After the t-statistics are all
computed, they are compared to the t-critical value T~t(α/2,3), or |T| > 3.187.

2.3 MIXED MODEL
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2.3.1. General Definition. A mixed model examines a relationship between a
response variable along with predictor variables that are observed or measured during the
experiment [9]. A key difference between a mixed model and a fixed effect model such
as the one way ANOVA previously described is a mixed model will treat at least one of
the variables as fixed while another is treated as random. The fixed effects have levels
that are of primary interest and could possibly be used again if the experiment were
repeated. Random effects have levels that are generally not of primary interest, but rather
are thought of as a random selection from a population. In the case of a repeated
measures experiment where the same subjects are measured across treatments or times,
generally subject effects will be the random effects, while different treatment levels are
the fixed effects. The idea behind the repeated measures mixed model is that the fixed
effects should tell how the population means differ between the set of treatments, while
the random effects represent the variability among measurements collected on the same
subjects or units. Another key difference between the ANOVA model and the repeated
measures mixed model is the way each computes the variance. The ANOVA model uses
moment estimators of the data to calculate the variance. It cannot work with missing data,
which can often be a problem when a study looks at data over time. This is an advantage
that the mixed model has over a general, one-way ANOVA. By default, the mixed model
uses a restricted maximum likelihood to calculate variance. This is helpful when there are
noise parameters or missing data. However, like the ANOVA model, the mixed model
allows testing multiple means at once. It is particularly useful when repeated
measurements are made on the same statistical units, or where measurements are made on
clusters of related statistical units since it incorporates any correlation between data
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collected on the same subject into the variance calculation. Because of this, it draws
similarities from both the paired t-test and the ANOVA model. The repeated measures
mixed model can be defined as:
Yij = µ + αi + ρj + εij. Where:
Yij is the observed response at fixed effect level i = 1, 2, …, a and random effect
level j = 1, 2, …, n.
µ is the overall mean response.
αi is the fixed main effect of level i = 1, 2, …, a and

a


i 1

i

0

iid

ρj is the random effect of level j,  j ~ N (0,   2 )
iid

εij is a random error term  ij ~ N (0,   2 )

The variance of the Yij is the total variance from the model and can be thought of as a
combination of the variance from both the error in the model summed with the
variance from the random effect. The proportion of the total variation in the response
due to within subject variation is the correlation coefficient and is defined as

 2
 2
. The ANOVA table for a mixed model is similar to a one way ANOVA
    2
table, however rather than only having a treatment effect, both the random and fixed
effect are included.
2.3.1.1 Assumptions. Since the repeated measures mixed model draws
similarities from both the ANOVA model and the paired t-test, there is a combination of
assumptions that should be met. First like the paired t-test, the data should be collected on
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the same statistical unit, or one should expect some correlation among the data. The
observations between the fixed effects should be independent, or one should not
influence another. The random subject should be normally distributed with a mean
centered at zero and with an unknown, similar variance. Also, the residuals should be
normally distributed, equally varying, and independent among one another. The same
diagnostic tests can be conducted as from the ANOVA model. One assumption that
largely differs from the general linear model is the sphericity assumption [9]. When the
mixed model is conducted and a repeated measures analysis is appropriate, the data does
not need to be assumed to have similar correlations between the treatments. While
compound symmetry (the sphericity assumption) is an option, there are also other options
for choosing a covariance structure that can improve the data analysis.
2.3.1.2 Compound symmetry vs. autoregressive model. If a mixed model is an
appropriate analysis for the data in question, it can be more powerful than a general linear
model because it can better account for missing data and also we can vary the covariance
matrix. Whenever a repeated measures mixed model is appropriate (that is, more than one
observation has been collected from a subject) choosing a within subject covariance
matrix is an important part of the analysis. The size of this matrix is determined by the
number of observations collected from the data. For example, if one measurement is
obtained at two different times, this will generate a 2x2 covariance matrix. If
measurements from 4 different treatments are applied to each subject, this will elicit a
4x4 matrix. The structure of this matrix is also crucial. The variance of the difference in
two within-subject means is calculated by:
Var (Y 1  Y 2 )  Var (Y 1 )  Var (Y 2 )  2Cov(Y 1 , Y 2 ) . The covariance term will make the

31

within subject comparisons more powerful than the between subject comparisons, since
this term is generally positive. The value of the covariance is determined by which
covariance matrix chosen. This is why it is very important to choose the correct
covariance structure for the analysis. The mixed model allows for many different types of
covariance matrices, but one common, simple type is called compound symmetry. This
covariance structure implies that each measured statistical unit is equally correlated with
one another and the total variation,
within unit component,

 2

 y2   2   2

, can be partitioned into the shared,

2
, and the unshared, or error component,   . The correlation

 2
coefficient   2
is assumed to be equal across all fixed effects and they all share a
    2
common error variance   . The compound symmetry within subject variance covariance
2

matrix is given below:

1   
 1   

 2 
  1  


   1 
One other type of covariance structure that can be used in a mixed model is called the
autoregressive model, or AR(1). Autoregressive is a term from times series analysis
which assumes observations are related to their own past values through the number of
lags between them [11]. An autoregressive structure implies that two observations closer
to each other over time or space should be more highly correlated than two observations
that are farther apart. The correlation coefficient between observations decreases (or
regresses) as difference between the observations become further apart. The AR(1) within
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subject covariance matrix is given below:

 1  2 3 


1  2 
2 

 2  1  
 3

2
 1
 
There are tests that can be conducted to help choose the best covariance structure for the
data. A likelihood ratio test can be conducted as well as observing two different
information criteria tests. The statistic that is observed for the likelihood ratio test is
called a -2log Likelihood statistic. This ratio test is used to calculate two information
criteria tests called the AIC (Akaike Information Criteria) and BIC (Bayesian Information
Criteria) statistics. Smaller AIC and BIC scores are ideal, so choosing the structure that
lowers these is a good idea.
2.3.1.3 Hypothesis tests for overall effects. The hypothesis test for the mixed
model is similar of that for the ANOVA model. The hypothesis being tested for the fixed
effects is:
Null Hypothesis: There is no difference between any of the population means for the
fixed effect levels, or α1 = α 2 = …= α a = 0 (where a = number of levels of the
fixed effect)
Alternative Hypothesis: At least one of the population means for the fixed effect levels
differs from the others, or α i ≠ 0 for at least one i.
The mixed model can also test whether there is significant within subject
variation. The tests are as follows:
Null Hypothesis:

 2  0
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Alternative Hypothesis:

 2  0

2.3.1.4 Test statistic. The test for the fixed effect is typically the primary test of
SS Fixed
MS Fixed
(a  1)
interest and the test statistic for this test is: F0 =
or
where a
SS Error
MS Error
(a  1)(n  1)

is the number of levels of the fixed effects and n is the total number of levels of the
random effect. Commonly, studies chose alpha to be 0.05 and obtain an F critical value
by Fα, a-1,(a-1)(n-1). This F critical value is compared to F0 and we reject the null hypothesis
when F0 > Fα, a-1,(a-1)(n-1). After F0 is compared to the F critical value, if one decides to
reject the hull hypothesis that one of the treatment means is indeed different than the
others, there are a few other tests that can be conducted to make statistical inferences
regarding the differences in treatment means.
2.3.1.5 Contrasts and pairwise comparisons. A contrast is a preplanned
comparison of the treatment means for some data set where L  c11  ...  ca a or

a

c 
i 1

i

and L is a linear combination of the treatment means, µi. An orthogonal contrast is a
contrast whose coefficients sum to zero. The sum of these cross products should also
equal zero. The numbers of different orthogonal contrasts that can be observed are equal
to the degrees of freedom for the treatment group, or the numerator degrees of freedom
from the overall F test for fixed effects. Contrasts are generally useful in analyzing preplanned comparisons for the data, or comparing treatment groups that the experimenters
might already suspect to have differences before analyzing data. The contrasts for the
mixed model are very similar to the contrasts for the ANOVA model. The difference

i
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between the two lies in the degrees of freedom. The degrees of freedom for the two tests
are different which results in the two tests having a different mean squared error as well.
There are many different hypotheses to test when examining contrasts. Assume
that the coefficients, ci sum to zero, a general way to write the hypothesis tests are as
follows:
a

H0:

c 
i 1

i

i

0

i

0

a

Ha:

c 
i 1

i

The test statistic for the different contrasts of a one-way ANOVA model each
follows a t-distribution. The estimate for the contrast is written in terms of the sample
a

treatment averages,

c y
i

i 1

i

and is compared to the mean square error. The test statistic is

a

as follows: t0 

c y
i 1

MS E
n

i

i

. This test uses the same degrees of freedom as the

a

c
i 1

2

i

denominator degrees of freedom from the overall F test for fixed effects and the null
hypothesis is rejected if |t0| > tα/2,(a-1)(n-1). The main difference in the contrasts and pairwise
comparisons from the ANOVA model and the mixed model is in the number of degrees
of freedom that are available. This changes the MSE as well as the entire ANOVA table.
The test statistic for the pairwise comparisons is similar to that of the contrasts. It also
follows a t-distribution and is written in terms of the treatment averages. However since it
is only testing the difference between two means, the general form is t0 =

yi  yi'
2
n

MS E

. Again
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this test statistic is compared to a critical t-value that is equal to tα/2,(a-1)(n-1) and we reject
the null hypothesis when |t0| > tα/2,(a-1)(n-1).
2.3.2. Microarray Data. The microarray data involves both a random (subject)
and fixed (time) effect, so a mixed model will hopefully elicit the best results due to the
correlation between the subjects over time. Because a new parameter is introduced into
the model (the random subject effect), the mixed model will have different degrees of
freedom than the one-way fixed effect ANOVA, particularly in the error term. One
degree of freedom is lost to the subject effect. The subject effect will have (n-1), or 1
degree of freedom. The fixed time effect still has 2 degrees of freedom, or (a-1). This
only leaves 2 degrees of freedom left for the error or (a-1)(n-1). This leaves less degrees
of freedom from the one-way ANOVA model, but since the data is measured over time,
the assumption that the data has some correlation over time will hopefully overcome that.
The repeated measures mixed model for the microarray data can be defined as:
Yij = µ + αi + ρj + εij. Where:
Yij is the expression level at time point i = 1, 2, 3 and subject j = 1, 2.
µ is the overall mean expression.
αi is the fixed effect, time at level i = 1, 2, 3.
iid

ρj is the random subject effect of level j = 1, 2  j ~ N (0,   2 )
iid

εij is a random error term  ij ~ N (0,   2 )
Normally there is an interaction term between the fixed and random variable that could
be considered in the model. However since our sample is very small, we could not afford
the degrees of freedom to include this in our analysis. Therefore we only examine main
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effects of subject and time.
2.3.2.1 Assumptions. For the mixed model to be a valid option for the microarray
data, several assumptions must be met. The data is collected on the same two individuals
over time since we are expecting some correlation or dependencies over time. However
the two individuals should not bear any influence on each other’s biological expression,
the different subjects should be independent of one another. The measured expressions
and the error are assumed to be normally distributed with a mean of zero and an unknown
variance. This assumption should also hold for the subject effect as well.
2.3.2.2 Hypothesis tests for overall effects. The hypotheses being tested for the
microarray data for the repeated measures mixed model for the fixed effects is as follows:
Null Hypothesis: There is no difference between any of the population means for the
fixed effect time, or α1 = α 2 = α 3 = 0
Alternative Hypothesis: At least one of the population means for the fixed effect time,
differs from the others, or α i ≠ 0 for at least one i where i = 1, 2, 3.

SS Fixed
MS Fixed
2 . The F critical value is
2.3.2.3 Test statistic. F0 =
or
SS
MS Error
Error
2
represented by Fα, 2,2 and is equal to 19.0. This F critical value is compared to F0 and we
reject the null hypothesis when F0 > 19. After F0 is compared to the F critical value and a
rejection decision has been made the contrasts and pairwise comparisons are conducted.
2.3.2.4 Contrasts and pairwise comparisons. For the microarray data all
possible orthogonal contrasts were tested. Since there are three different treatment groups
being considered, this leaves two degrees of freedom associated with the treatment effect.
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Therefore there are two different orthogonal contrasts to test. The first contrast for the
microarray data compares the mean of one treatment group to that of the other two or

C1  1  12 (2  3 ) . This is done three times so that each mean is compared to the other
two. The other orthogonal contrast compares only two of the means to each other. Again,
this contrast can be thought of as a pairwise comparison because it is comparing a set of
paired data. C2  1  2 is an example of one of the three paired comparisons for the
microarray data. A general form for the second orthogonal contrast is C2  i  i ' .
The hypothesis test for the first contrast, C1 for the microarray data is as follows:
Ho1: 2µ1 - µ2 - µ3 = 0 Ha1: 2µ1 - µ2 - µ3 ≠ 0
Ho2: 2µ2 - µ1 - µ3 = 0 Ha2: 2µ2 - µ1 - µ3 ≠ 0
Ho3: 2µ3 - µ1 - µ2 = 0 Ha3: 2µ3 - µ1 - µ2 ≠ 0
The hypothesis that is being tested for C1 is, whether the treatment means of group i
differs from the average of the other two treatment means. Each null hypothesis posits
that there is no difference between the population treatment means while the alternative
states that there is difference. The hypothesis test for C2 or the pairwise comparisons are
as follows:
Ho1: µ1 - µ2 = 0

Ha1: µ1 - µ2 ≠ 0

Ho2: µ1 - µ3 = 0

Ha2: µ1 - µ3 ≠ 0

Ho3: µ2 - µ3 = 0

Ha3: µ2 - µ3 ≠ 0

These hypotheses are testing to see if there is a difference between two of the treatments.
Again, each null hypothesis states that there is no difference between the two population
treatment means, the alternative stating otherwise.
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For the contrast C1 a t-statistic is calculated for each gene and exon. For the
pairwise comparisons, each gene and exon has a test statistic value. After the t-statistics
are all computed, they are compared to the t-critical value T~t(α/2,2), or |t| > 4.303. The
null hypothesis is rejected when the t-statistic is greater than the t-critical value.

2.4 EMPIRICAL BAYES
2.4.1. General Definition. The empirical Bayes or moderated t-test has
similarities to the independent t-test. Both of the tests analyze response measures from
two different populations. Just like comparing the paired and independent t-tests, inherent
differences exist for the empirical Bayes in how the degrees of freedom are calculated as
well as the variance for the data. The moderated t-test draws information from all of the
genes or exons contained in the analysis to improve the power of the t-test [12]. Rather
than estimating the variance for each gene or exon, the moderated t uses all genes/exons
to estimate the variance. The power of the test will increase because often times we are
able to gain a substantial amount of degrees of freedom as compared to both the
independent and paired t-test.
2.4.1.1 Assumptions. The assumptions for the moderated t-test are similar to that
of the independent t-test. The data collected should be from two different populations
should follow a normal distribution with equal variances. The populations should be

independent of one another and the observations within the populations should also be
independent.
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2.4.1.2 Hypothesis test. The moderated t-test has similar hypothesis tests to the
independent t-test as well. The test that is being conducted is still testing to see if there is
a difference between the two different population means.
Ho: There is no difference between the two population means or µi - µi’ = 0
Ha: There is a difference between the two population means or µi - µi’ ≠ 0
2.4.1.3 Test statistic. The moderated t-test is available in the Limma package
from Bioconductor in R. The Limma package is used for analyzing expression measures
for microarray data, or specifically experiments involving comparisons of many RNA
samples at the same time. Limma uses linear models to analyze the microarray
experiments.
This approach requires two matrices to be specified; a design matrix and a
contrast matrix. The design matrix provides a representation of the different RNA targets
hybridized to the arrays. The contrast matrix allows the coefficients defined by the design
matrix to be combined into contrasts of interest. Each contrast corresponds to a paired
comparison of interest between the RNA targets [12]. The expected value or mean as
well as the variance for each gene are computed via these matrices. A weight of the
matrix is used in conjunction with the variance of the biological expression. From these
two measurements the test statistic is calculated by t gj 

 gj
sg  gj

where g = the gene or

exon index and j = the specific contrast of interest. This test statistic is compared to the t
critical value and we reject the null hypothesis if |T| > t(α/2,dg + do). The  gj is equivalent to

y i  y i ' from the regular, independent t-test and the  gj is

2
n

when the sample sizes are
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equal. If the gene or exon is not differentially expressed, the difference between the two
population means will be zero. The sg is estimated via empirical Bayes method. From
Bayes’ theorem we assume a prior probability, p(θ|α) for  g2 that is based off of some
prior knowledge before any data has been collected. The parameters of the prior
probability are called hyperparameters, for  g2 these are do and so2 (degrees of freedom
and variance respectively). Some information is obtained strictly from the data as well.
This information is based off the likelihood, p(x|θ) and marginal likelihood, p(x|α) from
the data. The posterior probability p(θ|x,α) is a conditional probability of the parameters
given the prior knowledge and updated knowledge given from the data being analyzed.
The posterior distribution is calculated by p( | x,  ) 

p( x |  ) p( |  )
. Assuming the
p( x |  )

posterior distribution of  g2 follows some distribution, a mean and variance can be
estimated. The common variance estimated from the mean of the posterior  g2 is
2
g

calculated by s 

d o so2  d g sg2
do  d g

where do, so2 are the hyperparameters and sg2 and dg are

the sample variance and degrees of freedom equivalent to the one-way ANOVA. The
square root of this is used as the standard deviation in the moderated t-test. Truly
Bayesian statistics would allow the user to define the values of the hyperparameters do
and so2. However empirical Bayes methods estimate the hyperparameters from the data
and ultimately draw information from all of the genes or exons in doing so.
2.4.2. Microarray Data. The data being analyzed from this experiment does
come from a microarray experiment. RNA was collected from saliva samples resulting in
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numerous genes and exon expression measurements. This should be beneficial to the
analysis because the variance will be computed differently based on all of the genes and
exons as opposed to treating each one as its own entity. Also recalling the independent
and paired t-test, simply adding in one degree of freedom changed the critical t-value
immensely, allowing for more power in the test. We can expect to see an increase in the
degrees of freedom by using information from all of the genes or exons which should
allow for more of the tests to become significant when there are true differences in
expression.
2.4.1.1 Assumptions. As mentioned previously, the data does come from a
microarray experiment. The data comes from two normal populations, and the
observations are assumed to be independent from one another.
2.4.1.2 Hypothesis test. Again, the hypothesis test is similar to the independent ttest.
Null Hypothesis:
1.) There is no difference in expression measure between the baseline
and 24 hours of sleep deprivation: µ1 - µ2 = 0
2.) There is no difference in expression measure between the baseline
and 48 hours of sleep deprivation: µ1 - µ3 = 0
3.) There is no difference in expression measure between 24 and 48 hours of
sleep deprivation: µ2 - µ3 = 0

Alternative Hypothesis
1.) There is a difference between the means at baseline and 24 hours: µ1 - µ2 ≠ 0
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2.) There is a difference between the means at baseline and 48 hours: µ1 - µ3 ≠ 0
3.) There is a difference between the means at 24 and 48 hours: µ2 - µ3 ≠ 0
2.4.1.3 Test statistic. The test statistic from Formula (?) is calculated for each
gene and exon. The dg and sg are actually calculated the same way as we calculated the
degrees of freedom and MSE from the paired comparison in the ANOVA model. This
gives us three degrees of freedom for dg and a way to calculate sg. The do and so2 are a bit
more challenging to calculate however. The zj = log(sj2) follows a Fishers Z Distribution,
with mean and variance functions E(zj) = log so2 + ψ(dg/2) – ψ(do/2) + log(do/dg) and
Var(zj) = ψ’(dg/2) + ψ’(do/2) where ψ and ψ’ are the first and second derivatives of the
log of the gamma function. The final estimates for do and so are:
 1 J

d o  2 '1 
( z j  z )2  '(d g / 2)  and

 J  1 j 1

2





s o  exp z  (d g / 2)  (d o / 2)  log(d o / d g ) . For the microarray data gene level

analysis, do ≈ 2.15 and in the exon level analysis do ≈ 4.88. For the microarray data in
question, the total degrees of freedom for the gene level analysis is equal to 5.15. For the
exon level data the total degrees of freedom is equal to 7.88. The t-statistic is compared to
the critical t value and the null hypothesis is rejected when | tgi | > T~tα/2, do+dg or 2.571 for
the gene level analysis and 2.365 for the exon level analysis.
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3. REPEATED MEASURES VS INDEPENDENT TESTS

When conducting the above tests, there are several costs and benefits to choosing
to use an independent test versus a dependent test. In the independent tests, one assumes
that the data are completely independent within the subjects. The dependent tests assume
that there is some correlation in the data within the subjects. One thing that changes when
we make these different assumptions is the degrees of freedom. When the assumption is
that there is some correlation over time for the subjects, we lose a degree of freedom to
estimating this. However, the thought is that this degree of freedom can be made up for
by hopefully observing a smaller variance in the data when we assume this correlation.
Table 3.1 summarizes the analysis considered for these data.

Table 3.1 Dependent vs. Independent Measures
Independent Tests
Test

DFE

Independent T-Test
One-Way ANOVA

2
3

Moderated T-Test

5.15
(gene)
7.87
(exon)

Dependent Tests
Critical
Values
4.303
3.182
2.571
2.365

Test
Dependent T-Test
Repeated Measures
Mixed

DFE
1
2

Critical
Values
12.706
4.303

44

In observing the degrees of freedom from each test, it is very apparent that adding
degrees of freedom immensely improves the power analysis. However, what cannot be
seen in the tests above is what the variance estimates look like. For the t-tests the
variance is calculated in pairs for each comparison, or only two of the times are used to
compute the variance. Both the one-way ANOVA and repeated measures mixed model
draw information from all three time points to calculate the variance for each individual
gene or exon. The moderated t-test uses all of the time effects as well as all of the genes
or exons to calculate the variance. Tables 3.2 and 3.3 detail the variance parameter
estimates as well as the tradeoffs between the models.
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Table 3.2 Variance Estimators
Test

Variance Parameter Estimate

Independent

(n  1) s12  (n  1) s22
nn2

T-Test

n

 (d

Paired

j 1

T-Test

a

n

 (Y
i 1 j 1

ANOVA

ij

 Y i )2

N a

a

n

 (Y

Repeated
Measures
Mixed Model

T-Test

 d )2

n 1

One-Way

Moderated

j

Brief Explanation

i 1 j 1

ij

 Y i )2

(a  1)(n  1)



(1  

|i  j|

)



exp z  (d g / 2)  (d o / 2)  log(d o / d g )

Variance is likely larger since
we are not accounting for
repeated measures. Variance
estimates come from only the
two treatments being tested.
Variance is likely smaller
since data should have within
subject correlation. Variance
estimates come from only the
two treatments being tested.
Variance estimate should be
larger since this test does not
account for within subject
correlation. Variance
estimates come from all
treatments as opposed to
two.
Variance estimate should be
smaller because this test
accounts for within subject
correlation. Also the variance
estimate uses information
from all treatments as
opposed to two.
Variance estimate does not
account for within subject
correlation. However the
estimate uses all of the data
to generate a variance
estimate. This estimate could
be larger or smaller than the
estimate calculated in the
independent two sample ttest because the variance is
normalized.
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Table 3.3 Model Tradeoffs

2 2

(n  1) s12  (n  1) s22
nn2
n

 (d

j

j 1

 d )2

2 2
(1   )
n

n 1
a

n

 (Y
i 1 j 1

ij

n

 Y i )2

2 2

n

N a
a

n

 (Y
i 1 j 1

ij

 Y i )2

(a  1)(n  1)

(1  

|i  j|

)

2 2
(1   |i  j| )
n

Table 3.3 details the variance parameter estimates and true variance as well. It can
be seen that when there is indeed a positive correlation in the data, the repeated measures
models are beneficial. However when there is a negative correlation in the data, a
repeated measures analysis would not benefit the model. The variance for independent
two-sample t-test and paired t-test are plotted against each other below. The x-axis is the
pooled standard deviation (independent) and the y-axis is the paired standard deviation
(dependent).
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Figure 3.1 Variance Comparison from Baseline to 24 Hours

Figure 3.1 compares the variance between baseline and 24 hours for the
dependent and independent measures t-tests. The variance is smaller in 62.7% of the data
for the dependent measures tests.

48

Figure 3.2 Variance Comparison from Baseline to 48 Hours

Figure 3.2 compares the variance between baseline and 48 hours for the
dependent and independent measures t-tests. The variance is actually smaller for the
independent measures tests in 51.8% of the data. For the test comparing these time
points, the model is not improved at all using a dependent measures test.
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Figure 3.3 Variance Comparison from 24 to 48 Hours

Figure 3.3 compares the variance between 24 and 48 hours for the dependent and
independent measures t-tests. The variance is smaller for the dependent measures test for
61.6% of the data.
These graphs shown above in Figures 3.1-3.3 are shown simply to illustrate how
the variance changes when independent versus repeated measures are considered. In tests
that are closer in time the data has slightly less variation when a repeated measure is
used. For the test that compares times that are farther apart there is more variation when a
repeated measure is used.
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4. MULTIPLE TESTING CORRECTIONS

4.1 GENERAL DEFINITION
In statistics there are two types of errors that can be committed, type I and type II
error, both detailed in Figure 4.1.

Figure 4.1 Types of Statistical Errors

Type I error can be defined as rejecting the null hypothesis when it is indeed true.
In statistics, we assume that there will be some error in our analysis, but we can control
this error by setting a cutoff for the amount of error we are comfortable allowing. We call
this an alpha or significance level and it is thought of as the probability of making a type I
error. Type II error is the error that is committed when we fail to reject a false null
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hypothesis. This can be better controlled for by decreasing the noise or variability in the
data and increasing the sample size. The alpha level (from the type I error) can be kept
constant when conducting only one test. A problem occurs when more than one test is
being conducted on the data and the probability of making at least one type I error (across
all tests) is considered. This is called a multiple testing problem and it needs to be
controlled. The multiple corrections procedure looks at the issue of multiple testing by
adjusting the p-value from a family of hypothesis tests. An adjusted p-value is obtained
and is defined as the smallest significance level where the null hypothesis would be
rejected when the entire set of tests is considered [13]. After controlling for a family wise
error rate an alpha value is obtained and will be rejected if the adjusted p-value is less
than that alpha. The family wise error rate can be obtained by   1  1  {per comparison}  .
n

A popular test that uses FWER (family wise error rate) is a Bonferroni Correction [13].
This examines the probability of committing a type I error for any one of the m tests
being conducted on the data. This ends up resulting in the probability of committing a
type I error being less than or equal to the number of tests being conducted, m times the
alpha chosen (generally 0.05). We adjust the individual alpha, let this be α'. α' is equal to
the original, raw alpha over m or α'/m. This makes the resulting FWER extremely
conservative. Another popular type of corrections test that can be used is called False
Discovery Rate. The False Discovery Rate controls the expected proportion of false
positive among the significant tests [13]. For this type of correction one would compile
all of our paired hypothesis tests (H1, H2,…, Hm) with their corresponding raw p-values
(P1, P2,…, Pm) into one file, and arrange them in order from smallest to largest (P(1) ≤ P(2)
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≤ …≤ P(m))s. We let k equal the largest i where P(i ) 

i
 , and reject all H(i) i = 1, 2, …, k.
m

The FDR test assumes that all of the tests being conducted are independent of one
another.

4.2 MICROARRAY DATA
For the microarray data, thousands of genes and exons are being tested. For all of
the analysis above (t-tests, ANOVA, mixed model, and the moderated t-test) only raw pvalues were computed. Since so many analysis are being conducted, the type I error
cannot be kept at a constant level of alpha equal to 0.05. If we consider the gene level
analysis where over 17,000 genes made it into the final analysis, this makes the
probability of committing at least one type I error approximately equal to (1 – (1 –
0.05)17,000) ≈1. This makes the probability of rejecting the null hypothesis when it is
actually true extremely likely for at least one of our tests. If we consider the Bonferroni
Correction, the p-value will need to be less than 0.000003. The raw p-value for the exon
level analysis would be even smaller. For most microarray data there are generally
thousands of tests being conducted and this experiment is not an exception. Therefore
using the Bonferroni Correction can be considered a little bit too conservative. We opt for
using the False Discovery Rate option for the multiple testing corrections problem. All of
the hypothesis tests are aligned with their corresponding raw p-values. The p-values are
sorted from smallest to largest. The smallest raw p-value will be the first p-value given
and the largest raw p-value is the mth p-value (m tests are conducted). Somewhere in
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these thousands of tests, there is an i such that

P(i ) 

i

m . When this i is found, all of the

p-values that are smaller than this value are declared significant. For the microarray data,
we chose the corrected p-value to reject the null hypothesis to be 0.1 since this is
common in microarray studies.
The false discovery rate multiple corrections test assumes that all of the tests for
the genes or exons are independent of one another. This can be difficult because some of
the genes/exons can be dependent while others are independent, but is commonly
assumed anyway.
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5. GENE LEVEL ANALYSIS RESULTS

Figures 5.1-5.3 show volcano plots that are a common graphical summary for
microarray data. Data between the different time points are plotted using results from the
paired t-test without multiple testing corrections. The x-axis is the mean difference of the
time points while the y-axis is the standard deviation between the two times. The red
markers indicate that the gene was significantly differentially expressed from the two
time points while the grey shows non-significance. These graphs represent a way to
visualize how the size of the mean difference and the variation in the data affect
significance. Similar plots could be created for all of the analyses but these are shown for
demonstrative purposes.
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Figure 5.1 Volcano Plot from Baseline to 24 Hours
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Figure 5.2 Volcano Plot from Baseline to 48 Hours
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Figure 5.3 Volcano Plot from 24 to 48 Hours
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Figures 5.4-5.6 are another way to visualize the results by showing the log fold
change for the genes compared at the two time points using the paired t-test. The x-axis is
an ID variable that lists all of the genes. The y axis is the logfold change between the two
time points given. Again, the red points indicate that the gene was significantly
differentially expressed (for the raw p-value). We could have constructed these graphs for
other analyses too. These give an idea about logfold change and variance related to
significance.
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Figure 5.4 Log Fold Change from Baseline to 24 Hours
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Figure 5.5 Log Fold Change from Baseline to 48 Hours
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5.1 INDEPENDENT T-TEST

Table 5.1 gives the number of genes significantly, differentially expressed along
with the whether or not the gene was up or down regulated for the paired t-test without
multiple testing corrections. If a gene is up regulated it means that the expression
measure started lower and was measured significantly higher at the later time point.

Table 5.1 Significant Genes from the Independent T-Test
Independent T-Test Gene Level Data without Multiple Testing Corrections
Number
Number Down
Number Up
Test
Significant
Regulated
Regulated
Baseline to 24
1127
597
530
Hours
Baseline to 48
1475
720
755
Hours
24 to 48 Hours
912
505
407

Figure 5.7 is a venn diagram showing the number of significant genes at the different
testing times for the independent t-test. Here all genes are considered from the analysis.
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Baseline to 24 Hours

735
14,962
230

100
62

1035

148

Baseline to 48 Hours

602

24 to 48 Hours

Figure 5.7 Venn Diagram for Independent T-Test

After running the independent two sample t-tests, 3,514 significant differences were
obtained among the three different comparisons. Of these 1,822 were down regulated and 1,692
were up regulated. A total of 62 genes were significant in all three comparisons and 478 of them
were significant in two. However since so many (17,874) comparisons are performed on the same
data set, there is a greater chance of finding false significant differences. To address this problem,
the raw p values were entered into SAS and a multiple corrections procedure was performed.
Two of the results were significant after controlling for the multiple tests that were run on
the data at the alpha = 0.05 level. The genes that were significant were gene ID 3,130,823 and
2,470,165 and they were both significantly down regulated from 24 to 48 hours of sleep
deprivation. There was also one additional test that was significant at the alpha =0.1 level. Gene
ID 2,551,924 was up regulated from the test measuring from baseline to 48 hours.
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5.2 PAIRED T-TEST
Table 5.2 gives the number of genes significantly, differentially expressed along
with the whether or not the gene was up or down regulated for the paired t-test without
multiple testing corrections. If a gene is up regulated it means that the expression
measure started lower and was measured significantly higher at the later time point.

Table 5.2 Significant Genes from the Paired T-Test

Paired T-Test Gene Level Data without Multiple Testing Corrections
Number
Number Down
Number Up
Test
Significant
Regulated
Regulated
Baseline to 24
1003
474
529
Hours
Baseline to 48
1244
662
582
Hours
24 to 48 Hours
987
489
498

Figure 5.8 shows the number of significant genes significant at the different
testing times for the paired t-test. Here all genes are considered from the analysis.
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Baseline to 24 Hours
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Figure 5.8 Venn Diagram for Paired T-Test

After running the three paired t-tests, 3,234 significant differences among the
three different tests were found. Of these 1,625 were down regulated and 1,609 were up
regulated. A total of 45 genes were significant in all three comparisons and 131 of them
were significant in two. However since so many (17,874) tests were run on the same data
set, there is a greater chance of finding false significant differences. To address this
problem, the raw p values were entered into SAS and a multiple corrections test was
conducted.
None of the results were significant after controlling for the multiple tests that
were run on the data at the alpha = 0.05 level or the alpha = 0.1 level.
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5.3 ANALYSIS OF VARIANCE
Table 5.3 gives the number of genes significant for the one-way ANOVA
analysis. It is important to note that the tests for the pairwise comparisons only include
the data from the tests that were significant in the overall f test.

Table 5.3 Significant Genes from ANOVA Model
ANOVA Gene Level Data without Multiple Testing
Corrections
Number
Significant
1,257
Overall F
Contrast Baseline (different from 24 or 48)
930
Contrast 24 Hours (different from 24 or 48)
638
Contrast 48 Hours (different from 24 or 48)
BS is Different than 24
BS is Different than 48
24 is Different than 48

875
46
66
25

Up
Regulated
20
35
14

Down
Regulated
26
31
11

Figure 5.9 shows a Venn Diagram comparing the tests for the pairwise
comparisons for the one-way ANOVA model. Only the genes that were significant for
the overall f test were considered for the comparisons.
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Figure 5.9 Venn Diagram for ANOVA Model

From the Table 5.3 it is seen that there were 1,257 genes were significant for the
overall f test. Therefore, only the results for those 1,257 genes are listed for the pairwise
comparisons above in Table 5.3. The pairwise mean comparisons for the ANOVA model
show that of the 1,257 genes from the overall f test, 17 genes were differentially
expressed from baseline to 24 hours, 34 from baseline to 48 and 7 genes are significantly
different from 24 to 48 hours. Figure 5.9 shows the break down of how these genes were
differentially expressed. Five of the genes have significant paired comparisons for all
three of the comparisons while 1,162 were not significant for any of the paired
comparisons.
After the multiple testing corrections, there weren’t any siginificant genes at the
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alpha equals 0.05 level for the pairwise comparisons. Only one gene was significant at
the alpha = 0.1 level. Gene ID 2,844,453 was significantly down regulated from baseline
to 48 hours.

5.4 REPEATED MEASURES MIXED MODEL
Table 5.4 gives the number of genes significant for the repeated measures
analysis. It is important to note that the tests for the pairwise comparisons only include
the data from the tests that were significant in the overall f test.

Table 5.4 Significant Genes from Mixed Model
Mixed Model Gene Level Data without Testing
Corrections
Number
Significant
1,688
Compound Symmetry
2,092
Autoregressive Model
Contrast Baseline (AR1)
1,366
Contrast 24 Hours (AR1)
1,150
Contrast 48 Hours (AR1)
BS is Different than 24 (AR1)
BS is Different than 48 (AR1)
24 is Different than 48 (AR1)

1,225
892
1,021
728

Up
Regulated
470
593
362

Down
Regulated
422
428
366

Table 5.4. gives some information about the significant genes from the mixed
model analysis. Overall, when the compound symmetry covariance matrix was
implemented in the analysis, 1,688 genes had significant findings. The autoregressive
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model found more significant genes, however 1,464 were significant for both analyses as
shown in Figure 5.10.

224 1464 628

Compound Symmetry

Autoregressive

Figure 5.10 Covariance Matrix Comparison
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Figure 5.11 Venn Diagram for Repeated Measures Mixed Model

Since the autoregressive model found 2,092 significant genes for the overall f test
and the AIC found it to be a better fit for a larger percentage of the genes, only these
genes were examined for the pairwise comparisons. Of those 2,092 genes, 198 were
significant for all comparisons and 625 were not significant for any of the tests.
After the multiple testing corrections, none of genes were significant at the alpha equals
0.05 level for the pairwise comparisons. When alpha was raised to 0.1, the test comparing
baseline to 24 hours found two genes significantly differentially expressed. The test
comparing baseline to 48 hours found eight significant genes. The test comparing 24 to
48 hours found 3 significant genes.
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5.5 EMPIRICAL BAYES
Table 5.5 shows the number of genes that were significantly, differentially
expressed at the different testing times along with whether the gene was up or down
regulated.

Table 5.5 Significant Genes for Moderated T-Test
Moderated T-Statistic Gene Level Data without Multiple Testing Corrections
Number
Number Down
Number Up
Significant
Regulated
Regulated
1,579
940
639
Baseline to 24 Hours
1,986
1,202
784
Baseline to 48 Hours
1,205
553
652
24 to 48 Hours

Figure 5.12 is a Venn diagram that shows the number of genes significantly
differentially expressed for the moderated t-test.
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Baseline to 24 Hours

550
14,686
670

252
107

763

446

Baseline to 48 Hours

400

24 to 48 Hours

Figure 5.12 Venn Diagram for Moderated T-Test

As seen in Figure 5.12, 107 of the genes were significant for all three of the
moderated t-tests. 14,686 of the genes were not significant for any of the tests. 1,475 of
the tests were significant for at least two of the comparisons. To address the issue of a
multiple testing problem, a multiple corrections procedure is performed on the raw pvalues.
After running a multiple testing correction on the raw p-values for the moderated
t-statistic, there were 131 genes significant after allowing the alpha level to reach 0.1
from baseline to 48 hours. Of these 113 were down regulated and 18 were up regulated.
None of the other comparisons showed significant results for the multiple testing
corrections.
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6. EXON LEVEL ANALYSIS RESULTS

6.1 INDEPENDENT T-TEST
Table 6.1 gives the number of genes significantly, differentially expressed along
with the whether or not the gene was up or down regulated for the paired t-test without
multiple testing corrections. If a gene is up regulated it means that the expression
measure started lower and was measured significantly higher at the later time point.

Table 6.1 Significant Exons for Independent T-Test
Independent T-Test Exon Level Data without Multiple Testing Corrections
Number
Number Down
Number Up
Test
Significant
Regulated
Regulated
Baseline to 24
19,460
8,975
10,485
Hours
Baseline to 48
22,129
8,937
13,192
Hours
15,594
7,171
8,423
24 to 48 Hours

Figure 6.1 shows the number of significant genes significant at the different
testing times for the independent t-test.
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Baseline to 24 Hours

12,276
238,713
3,751

2,270
1,163

14,471

9,417

2,744

Baseline to 48 Hours

24 to 48 Hours

Figure 6.1 Venn Diagram for Independent T-Test

After running the three independent t-tests, 57,183 significant differences were found
among the three different tests. Of these 25,083 were down regulated and 32,100 were up
regulated. A total of 1,163 exons were significant in all three comparisons and 8,765 of them
were significant in two. However since so many tests are performed on the same data set, there is
a greater chance of finding false significant differences. To address this problem, the raw p values
were entered into SAS and a multiple corrections test was conducted.
None of the results from the multiple testing corrections were significant at either the
alpha equals 0.05 or alpha equals 0.1 significance levels.

6.2 PAIRED T-TEST
Table 6.2 shows the number of exons both up and down regulated for the paired t-

71

test.

Table 6.2 Significant Exons for Paired T-Test
Paired T-Test Exon Level Data without Multiple Testing Corrections
Number
Number Down
Number Up
Test
Significant
Regulated
Regulated
Baseline to 24
16,963
7,851
9,112
Hours
Baseline to 48
18,329
8,383
9,946
Hours
15,960
7,433
8,527
24 to 48 Hours

Figure 6.2 is a venn diagram that shows the number of significant genes
significant at the different testing times for the paired t-test.

Baseline to 24 Hours

9,987
244,078
3,167

2,781
1,028

11,613

2,521

Baseline to 48 Hours

9,630

24 to 48 Hours
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Figure 6.2 Venn Diagram for Paired T-Test

After running the three paired t-tests, 51,252 significant differences were found
among the three different tests. Of these 23,667 were down regulated and 27,585 were up
regulated. A total of 1,028 exons were significant in all three comparisons and 8,469 of
them were significant in two. However since so many tests are being ran on the same data
set, there is a greater chance of finding false significant differences. To address this
problem, the raw p values were entered into SAS and a multiple corrections test was
conducted.
Several of the results were significant after controlling for the multiple tests that
were run on the data at the alpha = 0.05 level. The exons that were significant and up
regulated for the comparison from baseline to 24 hours were probe set ID 3,031,827 and
2,640,916. None of the exons were significantly differentially expressed from baseline to
48 hours. Five exons were significantly down regulated from 24 to 48 hours, they are
probe set ID’s 3,525,655 2,665,526 3,718,502 2,443,537 and 3,130,823. Probe set ID
3,642,707 was significantly up regulated for this comparison as well. When alpha is
allowed to equal 0.1, two more exons are differentially expressed for that comparison as
well. They are probe set ID’s 3,922,793 and 2,995,476. No other tests were significant at
this level.

6.3 ANALYSIS OF VARIANCE
Table 6.3 gives the number of exons significantly expressed for each test
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conducted for the one-way ANOVA model. The only exons whose pairwise comparisons
were conducted were the 22,072 significant exons from the overall f test.

Table 6.3 Significant Exons for ANOVA Model

ANOVA Exon Level Data without Multiple Testing
Corrections
Number
Significant
22,072
Overall F
Contrast Baseline (different from 24 or 48)
15,684
Contrast 24 Hours (different from 24 or 48)
15,930
Contrast 48 Hours (different from 24 or 48)
BS is Different than 24
BS is Different than 48
24 is Different than 48

14,654
837
969
751

Up
Down
Regulated Regulated
402
435
509
460
397
354

Figure 6.3 compares the pairwise comparisons for significant exons.
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Baseline to 24 Hours

252
20,403
310

192
83

356

220

Baseline to 48 Hours

256

24 to 48 Hours

Figure 6.3 Venn Diagram for ANOVA Model

As seen in Figure 6.3, 83 of the exons were significant for all of the pairwise
comparisons. 722 of the comparisons were significant in two of the tests. 20,403 were not
significant in any of the comparisons. It is likely that these had other significant contrasts.
Because the pairwise comparisons were tested so many (284,805) times, a multiple
corrections test was conducted.
None of the pairwise comparisons were significant when for the multiple testing
corrections when alpha was equal to 0.05 or 0.1.
6.4 MIXED MODEL
Table 6.4 gives the number of exons significantly expressed for each test
conducted for the repeated measures mixed model. The only exons whose pairwise
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comparisons were conducted were the 25,739 significant exons from the overall f test.

Table 6.4 Significant Exons for Mixed Model
Mixed Model Exon Level Data without Multiple
Testing Corrections
Number Significant
25,739
Autoregressive Model
18,920
Contrast Baseline (AR1)
19,583
Contrast 24 Hours (AR1)
Contrast 48 Hours (AR1)
BS is Different than 24 (AR1)
BS is Different than 48 (AR1)
24 is Different than 48 (AR1)

17,061
1,332
1,340
1,007

Up
Regulated
679
701
518

Down
Regulated
653
639
489

Figure 6.4 shows a Venn diagram of the pairwise comparisons for the mixed
model analysis.
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Baseline to 24 Hours

443
23,070
397

304
188

462

293

Baseline to 48 Hours

222

24 to 48 Hours

Figure 6.4 Venn Diagram for Repeated Measures Mixed Model

Figure 6.4 shows that 188 of the exons were significant for all three of the
pairwise comparisons. 23,070 were not significant for any of the pairwise comparisons.
While there were 2,309 significant pairwise comparisons, a multiple corrections test
should be conducted since there are 284,805 tests being conducted on the data.
After running the multiple testing corrections on the data from the repeated
measures mixed model analysis, none of the exons were significant at either the 0.05 or
0.1 alpha levels.
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6.5 EMPIRICAL BAYES
Table 6.5 gives the number of exons significant for the moderated t-test for each
comparison. Also in the table is whether or not the exon was down or up regulated.

Table 6.5 Significant Exons for Moderated T-Test
Moderated T-Statistic Exon Level Data without Multiple Testing Corrections
Number
Number Down
Number Up
Significant
Regulated
Regulated
24,385
14,257
10,128
Baseline to 24 Hours
27,591
17,793
9,798
Baseline to 48 Hours
20,210
8,563
11,647
24 to 48 Hours

Figure 6.5 shows a Venn diagram comparing the moderated t-tests different
comparisons.
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Baseline to 24 Hours

9,930
234,321
8,597

4,881
977

11,747

6,270

Baseline to 48 Hours

8,082

24 to 48 Hours

Figure 6.5 Venn Diagram for Moderated T-Test
As seen in Figure 6.5, 977 of the exons were differentially expressed in all of the
tests. Tens of thousands of the tests were significant for more than one of the
comparisons. Because so many tests are being conducted on the same data set, a multiple
testing corrections test is ran to control for type I error.
When the alpha level is set at 0.05 for the multiple testing corrections one exon
was significant. Probe set ID 2,614,423 was significantly up regulated from baseline to
24 hours. When the alpha level increases to 0.1, hundreds of exons are significant. 739
are significant when comparing baseline to 48 hours. 608 of them were down regulated
and 131 were up regulated. Three additional exons were up regulated from baseline to 24
hours when alpha equals 0.1. Figure 6.6 compares the exons that are significant after
multiple testing corrections.
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1
Baseline to 24

3

736
Baseline to 48

Figure 6.6 FDR Significant Exons for Moderated T-Test
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7. CLUSTERING RESULTS

After running the different analyses, it was of interest to observe the relationship
pattern of the significantly expressed genes. Table 7.1 lists the genes that were
significantly expressed according to whether or not they were up or down regulated from
the paired t-test analysis. For example, gene ID 2,374,956 was significantly down
regulated from baseline to 24 hours and then again down regulated from 24 to 48 hours.
13 genes followed the down, down regulated pattern, 28 followed the up, up pattern, 25
were down regulated then up regulated and 31 went up and then down.
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Table 7.1 Significant Clustering Patterns for Genes
Down, Down
Up, Up
Down, Up
Up, Down
2374956
2356115
2497018
2344393
2403099
2362394
2536476
2438125
2404377
2363689
2643217
2499158
2527196
2391840
2646327
2565119
2844453
2434575
2674335
2840768
3065546
2526980
2841472
2949043
3135156
2527606
2844335
3159330
3212350
2599303
2876046
3165957
3284882
2738928
2945518
3272106
3403539
2982319
3091848
3301609
3737677
3114649
3161167
3316987
3753220
3167220
3186207
3361031
3980964
3372174
3256279
3364747
3377044
3364739
3413456
3377892
3455426
3453384
3392924
3474940
3464417
3393670
3477967
3525655
3569754
3620276
3556214
3635125
3757970
3592109
3676674
3764103
3638607
3728889
3841777
3672059
3739859
3861243
3683050
3819745
3958329
3696666
3837895
3959654
3699133
3844978
4016572
3727499
3854066
3749546
3860137
3800834
3869237
3822049
3918574
3959744
4052881
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Table 7.2 shows a truncated table of the clustering patterns for the significant
exons from the paired t-test. 112 followed a down, down pattern, 204 followed the up, up
pattern, 551 followed a down up pattern and 494 went up and then down.

Table 7.2 Truncated Significant Clustering Patterns for Exons
Down Down
Up Up
Down Up Up Down
2331704 2317447 2316462 2319149
2348680 2331556 2319855 2319451
2348905 2334705 2320641 2321257
2348965 2355671 2321044 2323094
2377042 2356117 2322293 2326361
2384716 2356127 2322883 2327552
2385261 2356136 2324400 2330120
2389037 2360040 2326860 2331474
2406985 2361423 2327020 2331683
2408012 2371023 2327348 2333266
2408546 2372879 2327632 2335173
2409978 2375675 2327831 2347177
2434978 2377271 2327836 2348096
2436304 2404161 2331426 2350505
2454210 2408269 2333654 2352313
2469571 2435866 2338529 2359038
2476245 2440478 2343100 2360114
2494777 2447461 2344435 2360713
2527977 2464529 2345007 2361425
2581019 2486986 2345102 2361847
2585364 2492026 2347098 2363542
2585370 2501229 2353507 2365876
2598264 2522646 2358972 2379904
2618530 2524019 2361845 2381044
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8. CONCLUSIONS

Since several genes and exons were significant after multiple testing corrections,
an obvious question is, whether any of the genes and exons are significant in more than
one test. A few of the genes were significant for two tests. Table 8.1 shows genes and
exons that are significant after multiple testing corrections, the comparison that it was
significant for, which test found it significant and whether it was up or down regulated.

Table 8.1 FDR Significant Genes and Exons

Exons
BS - 24

3,031,827
2,640,916

Test
Regulation BS - 48
PAIRED UP
PAIRED UP

Test

Regulation 24 - 48

3,525,655
2,665,526
3,718,502
2,443,537
3,130,823
3,642,707

Test
PAIRED
PAIRED
PAIRED
PAIRED
PAIRED
PAIRED

Regulation
DOWN
DOWN
DOWN
DOWN
DOWN
UP

Genes
BS - 24
Test
3,373,420 RMMM
4,047,607 RMMM

Regulation BS - 48
UP
2,551,924
UP
2,844,453
3,167,220
3,166,718
3,556,556
3,564,790
2,847,229
3,592,023
3,854,066

Test
INDEPENDENT T
ANOVA
RMMM
RMMM
RMMM
RMMM
RMMM
RMMM
RMMM

Regulation 24 - 48
UP
3,130,823
DOWN
2,470,165
DOWN
3,166,718
DOWN
3,942,007
DOWN
3,840,194
DOWN
DOWN
DOWN
DOWN

Test
INDEPENDENT T
INDEPENDENT T
RMMM
RMMM
RMMM

Regulation
DOWN
DOWN
UP
UP
DOWN

*Denotes Significant in Moderated t -test
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The 739 exons that were significant from the moderated t-test belonged to 568
different genes. Of those 568 genes, 61 of those were significant from the gene level
moderated t-test analysis. All of them were down regulated from baseline to 48 hours and
each gene is listed below in Table 8.2.

Table 8.2 Mapping Significant Exons to Significant Genes
2356115
2394680
2512930
2599303
2682271
2705706
2730173
2730194
2903401
2948887
2948926
2974635
3057955
3098977
3443891

3445786
3453837
3475794
3488985
3557947
3563317
3564790
3580179
3592023
3592511
3603408
3608113
3638411
3678462
3907190

3126087
3146433
3153328
3166718
3167220
3175119
3212294
3238761
3293762
3315675
3316208
3385175
3400625
3410384
3417457

3680953
3684486
3688311
3734379
3752258
3757078
3766893
3815243
3816380
3846831
3847005
3850261
3861948
3862018
3883971
4035833

When only examining raw p-values, thousands of genes and exons are
significantly differentially expressed. However because thousands of tests are conducted
on the same data set, the type I error rate must be controlled. Several of these were
significant after a multiple testing procedure as well. These genes and exons should be
examined closely to see if they play any role in sleep patterns or cycles. In order to claim
there is a causal relationship between these genes and exons and sleep, more microarray
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experiments should be conducted. Ideally the data would be collected on more
participants, possibly at smaller time intervals.
Finally for future analysis on this microarray data, perhaps it is not advantageous
to assume that the data is dependent. The dependence assumption forfeits a degree of
freedom and doesn’t show a large reduction in variance. It is important to note that this is
not the case for all microarray data. With a larger sample size, it would be possible to
investigate the correlation between expression measurements on the same individual
more in depth. However, for the data available in this study, it might be of interest to
conduct an analysis that treats some of the data as dependent and others as independent.
Perhaps conducting an analysis like this might result in more significant findings after
multiple testing corrections.

86

APPENDIX
COMMENTED SAS CODE
/* importing gene level csv file into SAS obtained from RMA method */
PROC IMPORT OUT= SASUSER.GENESHORTDATA
DATAFILE= "home\sb6xb\geneleveldata_short.csv"
DBMS=CSV REPLACE;
GETNAMES=YES;
DATAROW=2;
RUN;
/* transforming data into a different format */
data repeated;
set SASUSER.GENESHORTDATA;
exprs = exprsbsa; time = 1; sub
exprs = exprsbsb; time = 1; sub
exprs = exprs24a; time = 2; sub
exprs = exprs24b; time = 2; sub
exprs = exprs48a; time = 3; sub
exprs = exprs48b; time = 3; sub
drop exprs24a exprs24b exprs48a
proc sort data = repeated;
by gene;
run;

= 1; output;
= 2; output;
= 1; output;
= 2; output;
= 1; output;
= 2; output;
exprs48b exprsbsa exprsbsb;

/* creating data sets by time points; baseline, 24 hours, and 48 hours
*/
data time1;
/* baseline */
set repeated;
if time = 1;
drop obs;
rename time=time1;
rename exprs=exprs1;
run;
data time2;
/* 24 hours */
set repeated;
if time = 2;
drop obs;
rename time=time2;
rename exprs=exprs2;
run;
data time3;
/* 48 hours */
set repeated;
if time = 3;
drop obs;
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rename time=time3;
rename exprs=exprs3;
run;
/* merging time point data together, necessary to perform t tests */
data ttestdata;
merge time1 time2 time3;
by gene;
run;
/* turning off the output window in SAS */
ODS LISTING CLOSE;
/* creating a csv file path for t test comparing baseline to 24 hours
*/
ODS HTML FILE="E:\Thesis\exprs1exprs2.csv";
/* running t test comparing baseline to 24 hours */
proc ttest data=ttestdata;
paired exprs1*exprs2;
by gene;
/* creating ODS table name for t test data /*
ods output Ttests=ttest_output;
run;
/* printing the t test output to the csv file */
proc print data=ttest_output;
run;
/* creating a csv file path for t test comparing baseline to 48 hours
*/
ODS CSV FILE="E:\Thesis\exprs1exprs3.csv";
/* running t test comparing baseline to 48 hours */
proc ttest data=ttestdata;
paired exprs1*exprs3;
by gene;
/* creating ODS table name for t test data /*
ods output Ttests=ttest_output;
run;
/* printing the t test output to the csv file */
proc print data=ttest_output;
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run;
/* creating a csv file path for t test comparing 24 to 48 hours */
ODS CSV FILE="E:\Thesis\exprs2exprs3.csv";
/* running t test comparing 24 to 48 hours */
proc ttest data=ttestdata;
paired exprs2*exprs3;
by gene;
/* creating ODS table name for t test data /*
ods output Ttests=ttest_output;
run;
/* printing the t test output to the csv file */
proc print data=ttest_output;
run;
/* creating ODS table names for GLM procedures */
ods output overallANOVA=anova Contrasts=contr lsmeans=means diff=diff;
/* running proc glm in SAS */
proc glm data = repeated;
class sub time;
model exprs = time sub;
by gene;
/* creating contrasts comparing the time points */
contrast 'Baseline VS 24 and 48' time 2 -1 -1 / est;
contrast '24 VS Baseline and 48' time -1 2 -1 / est;
contrast '48 VS Baseline and 24' time -1 -1 2 / est;
/* creating comparison matrices for the time points */
lsmeans exprs / pdiff;
means exprs / tukey lsd;
run;
/* creating file path for contrast data */
ods csv file='E:\Thesis\contrasts.csv';
/* printing contrast table to csv file */
proc print data=contr;
run;
/* creating file path for p values and anova table data */
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ods csv file='E:\Thesis\anovafvalues.csv';
/* printing p values and anova table data to csv file*/
proc print data=anova;
run
/* creating file path for difference matrix data */
ods csv file='E:\Thesis\pdiff.csv';
/* printing difference matrices to csv file */
proc print data=diff;
run
/* creating ODS table names for mixed procedures */
ods output covparms=cp asycov=asy infocrit=aic tests1=tests1
contrasts=contr diff=diff;
/* running the mixed procedure in SAS */
proc mixed data=repeated covtest asycov ic;
class sub time;
model exprs = time / s htype=1;
by gene;
/* creating contrasts comparing the time points */
contrast 'BS VS 24 and 48' time 2 -1 -1 / est;
contrast '24 VS BS and 48' time -1 2 -1 / est;
contrast '48 VS BS and 24' time -1 -1 2 / est;
/* creating comparison matrices for the time points */
lsmeans time / pdiff=all;
repeated time / TYPE = AR(1) subject=sub r;
run;
/* specifying file path for ODS table data, difference matrices */
ods csv file="E:\Thesis\pdiffmixed.csv";
/* printing csv file, difference matrices */
proc print data=diff;
run;
/* specifying file path for ODS table data, AIC scores */
ods csv file="E:\Thesis\geneaicscorear1.csv";
/* printing csv file, AIC score */
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proc print data=aic;
run;
/* specifying file path for ODS table data, p values and anova tables
*/
ods csv file="E:\Thesis\genemixedpvaluesar1.csv";
/* printing csv file, pvalues and anova tables */
proc print data=tests1;
run;
/* specifying file path for ODS table data, residual variances */
ods csv file="E:\Thesis\mixedwresidualar1.csv";
data res;
set cp;
if subject = 'sub' then
delete;
run;
/* printing csv file, residual variances */
proc print data=res;
run;
/* specifying file path for ODS table data, subject variances */
ods csv file="E:\Thesis\mixedwsubjectar1.csv";
data sub;
set cp;
if subject = ' ' then
delete;
run;
/* printing csv file, subject variances */
proc print data=sub;
run;
/* importing in raw p value data from t tests */
PROC IMPORT OUT= SASUSER.GENEMULTTEST
DATAFILE= "E:\Thesis\genemulttest.csv"
DBMS=CSV REPLACE;
GETNAMES=YES;
DATAROW=2;
RUN;
/* cutting data to only include necessary p values from first t test */
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data multtest1;
set sasuser.genemulttest;
rename probt12=Raw_P;
drop prob13;
drop prob23;
run;
/* specifying file path for output table to print to */
ods csv file="E:/Thesis/ttestgenemulttest12.csv";
/* running the multiple testing corrections adjustment in SAS using fdr
*/
proc multtest inpvalues=multtest1 fdr;
run;
/* cutting data to only include necessary p values from second t test
*/
data multtest2;
set sasuser.genemulttest;
rename prob13=Raw_P;
drop probt12;
drop prob23;
run;
/* specifying file path for output table to print to */
ods csv file="E:/Thesis/ttestgenemulttest13.csv";
/* running the multiple testing corrections adjustment in SAS using fdr
*/
proc multtest inpvalues=multtest2 fdr;
run;
/* cutting data to only include necessary p values from third t test */
data multtest3;
set sasuser.genemulttest;
rename prob23=Raw_P;
drop prob13;
drop probt12;
run;
/* specifying file path for output table to print to */
ods csv file="E:/Thesis/ttestgenemulttest23.csv";
/* running the multiple testing corrections adjustment in SAS using fdr
*/
proc multtest inpvalues=multtest3 fdr;
run;
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/*Multiple testing corrections file for ANOVA, MIXED, and MOD T*/
/* importing data into SAS on the NIC Cluster */
PROC IMPORT OUT= SASUSER.EXONSHORTdata
DATAFILE= "home\sb6xb\exonleveldata_short.csv"
DBMS=CSV REPLACE;
GETNAMES=YES;
DATAROW=2;
RUN;
/* transforming data into a different format */
data ttest;
set sasuser.exonshortdata;
exprs = bsa_cel; time = 1; sub = 1; output;
exprs = bsb_cel; time = 1; sub = 2; output;
exprs = x24a_cel; time = 2; sub = 1; output;
exprs = x24b_cel; time = 2; sub = 2; output;
exprs = x48a_cel; time = 3; sub = 1; output;
exprs = x48b_cel; time = 3; sub = 2; output;
drop bsa_cel bsb_cel x24a_cel x24b_cel x48a_cel x48b_cel;
proc sort data = ttest;
by probesetid;
run;
/* creating data sets by time points; baseline, 24 hours, and 48 hours
*/
data time1;
/* baseline */
set repeated;
if time = 1;
drop obs;
rename time=time1;
rename exprs=exprs1;
run;
data time2;
/* 24 hours */
set repeated;
if time = 2;
drop obs;
rename time=time2;
rename exprs=exprs2;
run;
data time3;
/* 48 hours */
set repeated;
if time = 3;
drop obs;
rename time=time3;
rename exprs=exprs3;
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run;
/* merging time point data together, necessary to perform t tests */
/* creating a csv file path for t test comparing baseline to 24 hours
*/
ODS HTML FILE="E:\Thesis\exprs1exprs2.csv";
/* running t test comparing baseline to 24 hours */
proc ttest data=ttestdata;
paired exprs1*exprs2;
by probesetid;
/* creating ODS table name for t test data /*
ods output Ttests=ttest_output;
run;
/* printing the t test output to the csv file */
proc print data=ttest_output;
run;
/* creating a csv file path for t test comparing baseline to 48 hours
*/
ODS CSV FILE="E:\Thesis\exprs1exprs3.csv";
/* running t test comparing baseline to 48 hours */
proc ttest data=ttestdata;
paired exprs1*exprs3;
by probesetid;
/* creating ODS table name for t test data /*
ods output Ttests=ttest_output;
run;
/* printing the t test output to the csv file */
proc print data=ttest_output;
run;
/* creating a csv file path for t test comparing 24 to 48 hours */
ODS CSV FILE="E:\Thesis\exprs2exprs3.csv";
/* running t test comparing 24 to 48 hours */
proc ttest data=ttestdata;
paired exprs2*exprs3;
by probesetid;
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/* creating ODS table name for t test data /*
ods output Ttests=ttest_output;
run;
/* printing the t test output to the csv file */
proc print data=ttest_output;
run;
/* creating ODS table names for GLM procedures */
ods output overallANOVA=anova Contrasts=contr lsmeans=means diff=diff;
/* running proc glm in SAS */
proc glm data = repeated;
class sub time;
model exprs = time sub;
by probesetid;
/* creating contrasts comparing the time points */
contrast 'Baseline VS 24 and 48' time 2 -1 -1 / est;
contrast '24 VS Baseline and 48' time -1 2 -1 / est;
contrast '48 VS Baseline and 24' time -1 -1 2 / est;
/* creating comparison matrices for the time points */
lsmeans exprs / pdiff;
means exprs / tukey lsd;
run;
/* creating file path for contrast data */
ods csv file='E:\Thesis\exoncontrasts.csv';
/* printing contrast table to csv file */
proc print data=contr;
run;
/* creating file path for p values and anova table data */
ods csv file='E:\Thesis\exonanovafvalues.csv';
/* printing p values and anova table data to csv file*/
proc print data=anova;
run
/* creating file path for difference matrix data */
ods csv file='E:\Thesis\exonpdiff.csv';
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/* printing difference matrices to csv file */
proc print data=diff;
run;
/* creating ODS table names for mixed procedures */
ods output covparms=cp asycov=asy infocrit=aic tests1=tests1
contrasts=contr diff=diff;
/* running the mixed procedure in SAS */
proc mixed data=repeated covtest asycov ic;
class sub time;
model exprs = time / s htype=1;
by probesetid;
/* creating contrasts comparing the time points */
contrast 'BS VS 24 and 48' time 2 -1 -1 / est;
contrast '24 VS BS and 48' time -1 2 -1 / est;
contrast '48 VS BS and 24' time -1 -1 2 / est;
/* creating comparison matrices for the time points */
lsmeans time / pdiff=all;
repeated time / TYPE = AR(1) subject=sub r;
run;
/* specifying file path for ODS table data, difference matrices */
ods csv file="E:\Thesis\exonpdiffmixed.csv";
/* printing csv file, difference matrices */
proc print data=diff;
run;
/* specifying file path for ODS table data, AIC scores */
ods csv file="E:\Thesis\exongeneaicscorear1.csv";
/* printing csv file, AIC score */
proc print data=aic;
run;
/* specifying file path for ODS table data, p values and anova tables
*/
ods csv file="E:\Thesis\exonmixedpvaluesar1.csv";
/* printing csv file, pvalues and anova tables */
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proc print data=tests1;
run;
/* specifying file path for ODS table data, residual variances */
ods csv file="E:\Thesis\exonmixedwresidualar1.csv";
data res;
set cp;
if subject = 'sub' then
delete;
run;
/* printing csv file, residual variances */
proc print data=res;
run;
/* specifying file path for ODS table data, subject variances */
ods csv file="E:\Thesis\exonmixedwsubjectar1.csv";
data sub;
set cp;
if subject = ' ' then
delete;
run;
/* printing csv file, subject variances */
proc print data=sub;
run;
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